NCT01488240 The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars
| NCT ID | NCT01488240 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Manitoba |
| Condition | Burn Scar |
| Study Type | INTERVENTIONAL |
| Enrollment | 6 participants |
| Start Date | 2012-11-01 |
| Primary Completion | 2028-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 6 participants in total. It began in 2012-11-01 with a primary completion date of 2028-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine the effects (good or bad) of pulsed dye laser treatment in burn scar height, texture, redness and pliability in acute burn injury.
Eligibility Criteria
Inclusion Criteria: * burn scar * living in Winnipeg * scar age one to 6 months * Fitzpatrick I-III skin type Exclusion Criteria: * open wound * active infection * previous scar treatment with steroid injection or interferon * established disposition towards keloid scarring
Contact & Investigator
S Logsetty, MD
PRINCIPAL INVESTIGATOR
University of Manitoba
Frequently Asked Questions
Who can join the NCT01488240 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Burn Scar. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01488240 currently recruiting?
Yes, NCT01488240 is actively recruiting participants. Contact the research team at jgawaziuk@hsc.mb.ca for enrollment information.
Where is the NCT01488240 trial being conducted?
This trial is being conducted at Winnipeg, Canada.
Who is sponsoring the NCT01488240 clinical trial?
NCT01488240 is sponsored by University of Manitoba. The principal investigator is S Logsetty, MD at University of Manitoba. The trial plans to enroll 6 participants.